Read about Endologix
in the news

Embrace the evidence.

The Latest:

Endologix Announces 36-Month Results of DETOUR2 Study at 2024 VIVA Late-Breaking Clinical Trial Session

See Release

All News

Archives

Endologix Announces CE Mark Approval for the Nellix® EndoVascular Aneurysm Sealing System with the Refined Indications for Use

Endologix Announces Collaboration Agreements with Japan Lifeline for the Development and Commercialization of Thoracic Endovascular Systems in Japan

Endologix Announces Positive Clinical Results from the LEOPARD Clinical Study

Endologix Presents Positive Two-Year Clinical Data from the Nellix® EVAS FORWARD IDE Trial

Endologix Reports Positive Clinical Data from the Ovation LUCY Study